awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q39269556-78734104-6145-4857-8565-B94A89627DBD
Q39269556-78734104-6145-4857-8565-B94A89627DBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39269556-78734104-6145-4857-8565-B94A89627DBD
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer.
P2860
Q39269556-78734104-6145-4857-8565-B94A89627DBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39269556-78734104-6145-4857-8565-B94A89627DBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fc4a443b5acb73dda30aa4f0c87468a3d2f0e6d
P2860
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer.